NEXT FUNDS TOPIX-17 PHARMACEUTICAL ETF (1621.TSE) — Technical state
As of 2026-09-04 — re-computed nightly across the coverage universe. Closelook diary readings, not advice.
Trades +1.1% vs the 50-day and -0.1% vs the 200-day average, 11.2% below the 52-week high and +17.5% off the 52-week low; a death cross printed 44 sessions ago. Computed from daily closes.
The moving-average stack
- vs 20-day-0.9%
- vs 50-day+1.1%
- vs 200-day-0.1%
- 52-week band11.2% off the high · +17.5% off the low
- Streak1 consecutive down session
- CrossoverDeath cross 44 sessions ago
- 50-day crossprice crossed up through the 50-day 20 sessions ago
- Stochastic%K 40.2 · %D 74.4 · bear cross
Continue: the 1621.TSE chart & overview · the signal board
FAQ · from the current data · as of 2026-09-04
Quick answers
What is the current Closelook signal on 1621.TSE?
Recovery attempt under the 200-day — Trades +1.1% vs the 50-day and -0.1% vs the 200-day average, 11.2% below the 52-week high and +17.5% off the 52-week low; a death cross printed 44 sessions ago. Computed from daily closes. As of 2026-09-04; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.
Is 1621.TSE above its 50-day and 200-day moving averages?
As of 2026-09-04, NEXT FUNDS TOPIX-17 PHARMACEUTICAL ETF trades +1.1% above its 50-day and -0.1% below its 200-day average, with the 20-day -0.9% away.
How far is 1621.TSE from its 52-week high?
11.2% below the 52-week high and 17.5% above the 52-week low, as of 2026-09-04.